Janux Therapeutics (JANX) had the highest return in February 2024 by a small-cap US stock, returning 456.1%.

ASSET	MONTH	% RETURN
Janux Therapeutics (JANX)	February 2024	456.09%
Root (ROOT)	February 2024	290.16%
Palladyne AI (PDYN)	February 2024	161.11%
Monopar Therapeutics (MNPR)	February 2024	147.02%
Gaotu Techedu Inc DRC (GOTU)	February 2024	132.74%
Solowin Holdings Ordinary Share (SWIN)	February 2024	124.9%
flyExclusive (FLYX)	February 2024	114.18%
Jumia Technologies (JMIA)	February 2024	108.56%
Taysha Gene Therapies (TSHA)	February 2024	104.53%
BigBearai (BBAI)	February 2024	103.64%
Iovance Biotherapeutics (IOVA)	February 2024	102.68%
Larimar Therapeutics (LRMR)	February 2024	102.11%
Trevi Therapeutics (TRVI)	February 2024	100%
Emergent Biosolutions (EBS)	February 2024	93.41%
Sana Biotechnology (SANA)	February 2024	82.88%
Katapult Holdings Equity Warrants Exp 09 June 2026 (KPLTW)	February 2024	78.33%
Acm Research (ACMR)	February 2024	76.89%
Ocugen (OCGN)	February 2024	75.22%
Hyliion (HYLN)	February 2024	73.33%
Spire Global (SPIR)	February 2024	73.18%
Selectquote (SLQT)	February 2024	70.18%
Benitec Biopharma Ltd ADR (BNTC)	February 2024	69.58%
Byrna Technologies (BYRN)	February 2024	69.07%
GigaCloud Technology Inc Class A Ordinary Shares (GCT)	February 2024	67.56%
SS Innovations International Inc Common Stock (SSII)	February 2024	64.63%

Small-cap stocks are treated as having a market cap between $300M and $2B.